Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE Study

Clinical trial NCT04823247 · COMPLETED

Trial details

NCT number: NCT04823247
Sponsor: Almirall, S.A.
Status: COMPLETED
Study type: OBSERVATIONAL

Plaque Psoriasis

Start date: 2021-11-22
Primary completion: 2025-01-09
Enrollment: 782

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.